Gemcitabine-induced thrombotic microangiopathy: a systematic review (original) (raw)

The cumulative incidence of gemcitabine-induced thrombotic microangiopathy

JÓn Hrafnkelsson

Acta Oncologica, 2007

View PDFchevron_right

Gemcitabine-associated thrombotic microangiopathy

Jeff Sharman

Cancer, 2004

View PDFchevron_right

Gemcitabine-Induced Thrombotic Microangiopathy Managed Conservatively in a Patient of Breast Cancer

Vinod Khatri

Cureus

View PDFchevron_right

Drug-induced Thrombotic Microangiopathy Caused by Gemcitabine

Huda Naim

Cureus, 2018

View PDFchevron_right

Thrombotic microangiopathy and digital necrosis: two unrecognized toxicities of gemcitabine

Heang Ly

Anti-Cancer Drugs, 2003

View PDFchevron_right

Improvement in Gemcitabine-Induced Thrombotic Microangiopathy with Rituximab in a Patient with Ovarian Cancer: Mechanistic Considerations

iyad mansour

Case Reports in Nephrology and Dialysis, 2015

View PDFchevron_right

The use of eculizumab in gemcitabine induced thrombotic microangiopathy

Vinod Krishnappa

BMC nephrology, 2018

View PDFchevron_right

Gemcitabine-associated thrombotic microangiopathy – a role for eculizumab?

Teresa Chuva

Portuguese Journal of Nephrology & Hypertension, 2020

View PDFchevron_right

Thrombotic microangiopathy (TMA) in adult patients with solid tumors: a challenging complication in the era of emerging anticancer therapies

carme font

Supportive Care in Cancer

View PDFchevron_right

Thrombotic microangiopathy in cancer

Ilene Weitz

Thrombosis Research

View PDFchevron_right

Gemcitabine-Induced Extensive Skin Necrosis

Roberto Iacovelli, Cecilia Luci

Case Reports in Medicine, 2012

View PDFchevron_right

Haemolytic uraemic syndrome associated with gemcitabine

E. Gallardo

Clinical and Translational Oncology, 2010

View PDFchevron_right

Thrombotic microangiopathy related to anti-VEGF agents: intensive versus conservative treatment?

edward Bourry

Annals of Oncology, 2011

View PDFchevron_right

Fatal pulmonary veno-occlusive disease possibly related to gemcitabine

Eric Verbeken

Lung Cancer, 2001

View PDFchevron_right

Chronic Thrombotic Microangiopathy Secondary to Chemotherapy for Urothelial Carcinoma in a Patient With a History of Wegener Granulomatosis

Sanjeev Sethi

American Journal of Kidney Diseases, 2011

View PDFchevron_right

Retrospective analysis of adverse drug reactions induced by gemcitabine treatment in patients with non-small cell lung cancer

M. Nardi, Manuela Colosimo

Pharmacological Research, 2004

View PDFchevron_right

Role of eculizumab in a pediatric refractory gemcitabine-induced thrombotic microangiopathy: a case report

Alessia Stival

Journal of Medical Case Reports, 2017

View PDFchevron_right

Gemcitabine-Induced Hemolytic Uremic Syndrome in Lung Cancer: A Case Report

Faida Musaad

Cureus, 2022

View PDFchevron_right

Gemcitabine-induced hemolytic uremic syndrome in ovarian carcinoma

Sayed Osama

International Journal of Clinical Oncology, 2007

View PDFchevron_right

Hematologic toxicity of gemcitabine: a comparison between fixed-dose rate infusion and thirty-minute infusion in the treatment of malignancy

Xi Liu

The Chinese-German Journal of Clinical Oncology, 2012

View PDFchevron_right

Gemcitabine-associated thrombotic thrombocytopenic purpura

Farheen Shah-Khan

The Lancet Oncology, 2007

View PDFchevron_right

Gemcitabine/Capecitabine in Patients with Metastatic Breast Cancer Pretreated with Anthracyclines and Taxanes

Rodrigo Lastra

Clinical Breast Cancer, 2005

View PDFchevron_right

www.karger.com Clinical Study Oncology 2007;73:221–227 DOI: 10.1159/000127413 Oral Capecitabine in Gemcitabine- Pretreated Patients with Advanced

Alexander Golf

2015

View PDFchevron_right

Gemcitabine-induced Hemolytic Uremic Syndrome Mimicking Scleroderma Renal Crisis Presenting with Raynaud's Phenomenon, Positive Antinuclear Antibodies and Hypertensive Emergency

Sayed Osama

Internal Medicine, 2014

View PDFchevron_right

A Phase II Study of Gemcitabine and Capecitabine in Patients With Advanced Renal Cell Cancer

John Gibbs

American Journal of Clinical Oncology, 2009

View PDFchevron_right

Gemcitabine-induced Acute Lipodermatosclerosis-like Reaction

cy chu

Acta Dermato-Venereologica, 2001

View PDFchevron_right

Eculizumab therapy for gemcitabine induced hemolytic uremic syndrome: case series and concise review

Pradeep Arora

Journal of gastrointestinal oncology, 2014

View PDFchevron_right